Global Health Clinics (TSE:MJRX)

:MJRX

MJRX

Global Health Clinics

RESEARCH TOOLSreports

Want to see TSE:MJRX full AI Analyst Report?

Global Health Clinics (MJRX) Price & Analysis

0 Followers

MJRX Stock Chart & Stats

C$0.02

C$0.00(0.00%)

At close: Dec 20 4:00 PM EST

C$0.02

C$0.00(0.00%)

Day’s Range― - ―

52-Week RangeC$0.01 - C$0.09

Previous CloseN/A

Volume0.00

Average Volume (3M)7.79K

Market Cap

C$422.65K

Enterprise ValueC$3.26M

Total Cash (Recent Filing)C$43.85K

Total Debt (Recent Filing)C$2.78M

Price to Earnings (P/E)―

Beta-1.33

Next Earnings

Jun 25, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.14

Shares Outstanding9,392,138

10 Day Avg. Volume900

30 Day Avg. Volume7,790

Financial Highlights & Ratios

PEG Ratio>-0.01

Price to Book (P/B)-0.02

Price to Sales (P/S)1.97

P/FCF Ratio-0.16

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Modest Historical Debt LevelAlthough debt has increased recently to ~2.8M TTM, the company’s history of modest absolute debt provides some structural breathing room versus highly levered peers. That prior low leverage can make short-term refinancing or incremental borrowing easier if operational fixes restore confidence.

Reduced TTM Operating Cash OutflowA smaller operating cash outflow on a TTM basis versus prior years suggests cost controls or partial stabilization in cash use. If this trend persists, it improves runway and reduces dependence on immediate external funding, allowing more time to execute restructuring or commercialization plans.

Industry: Specialty & Generic DrugsOperating in the specialty & generic pharmaceuticals sector exposes the company to structurally recurring demand and multiple commercial pathways (generics, niche therapies, contract manufacturing). These industry characteristics can provide durable market opportunities if product execution and regulatory compliance are achieved.

Bears Say

Severe Revenue Decline And Negative Gross ProfitPersistent, sharp revenue declines combined with negative gross profit indicate the core business is not covering direct costs. This undermines operating leverage and makes margin recovery difficult without substantive revenue growth or cost restructuring, limiting sustainable profitability over the medium term.

Negative Equity And Rising DebtConsistently negative shareholders' equity with rising debt and minimal assets creates acute solvency and liquidity risk. The stressed capital structure reduces financial flexibility, increases refinancing and dilution risk, and impairs the company’s ability to invest or withstand prolonged downturns without major external recapitalization.

Persistent Negative Cash GenerationOngoing negative operating and free cash flow across periods signals chronic cash burn. Reliance on external funding to sustain operations impedes long-term planning, restricts investment in R&D or commercialization, and increases the probability of dilutive financing or distress if cash flow does not turn positive.

MJRX FAQ

What was Global Health Clinics’s price range in the past 12 months?

Global Health Clinics lowest stock price was C$0.01 and its highest was C$0.09 in the past 12 months.

What is Global Health Clinics’s market cap?

Global Health Clinics’s market cap is C$422.65K.

When is Global Health Clinics’s upcoming earnings report date?

Global Health Clinics’s upcoming earnings report date is Jun 25, 2026 which is in 13 days.

How were Global Health Clinics’s earnings last quarter?

Global Health Clinics released its earnings results on Mar 27, 2026. The company reported -C$0.036 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.036.

Is Global Health Clinics overvalued?

According to Wall Street analysts Global Health Clinics’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Global Health Clinics pay dividends?

Global Health Clinics does not currently pay dividends.

What is Global Health Clinics’s EPS estimate?

Global Health Clinics’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Global Health Clinics have?

Global Health Clinics has 9,392,138 shares outstanding.

What happened to Global Health Clinics’s price movement after its last earnings report?

Global Health Clinics reported an EPS of -C$0.036 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Global Health Clinics?

Currently, no hedge funds are holding shares in TSE:MJRX

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Global Health Clinics

Operating within the cannabis industry, Global Health Clinics Ltd. manages medical facilities that provide guidance to patients seeking to legally obtain and use marijuana. The company is also involved in creating psilocybin products designated for scientific research and pharmaceutical development. It was formerly known as Leo Resources Inc., changing its name to Global Health Clinics Ltd. in August 2018. Established in 2013, its primary operations are based in Vancouver, Canada.